LockdownV1, Main, Exploration, bibRecord, 000673

Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.

Identifieur interne : 000673 ( Main/Exploration ); précédent : 000672; suivant : 000674

Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.

Auteurs : Gianluca Vanni [Italie] ; Marco Pellicciaro [Oman] ; Marco Materazzo [Italie] ; Valentina Bruno [Italie] ; Chiara Oldani [Italie] ; Chiara Adriana Pistolese [Italie] ; Chiara Buonomo [Italie] ; Jonathan Caspi [Italie] ; Paola Gualtieri [Italie] ; Agostino Chiaravalloti [Italie] ; Leonardo Palombi [Italie] ; Emilio Piccione [Italie] ; Oreste Claudio Buonomo [Italie]

Source :

In vivo (Athens, Greece) [ 1791-7549 ]

RBID : pubmed:32871851

Descripteurs français

KwdFr :
- Adulte d'âge moyen (MeSH), Betacoronavirus (pathogénicité), Dépistage de masse (tendances), Dépistage précoce du cancer (MeSH), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (complications), Infections à coronavirus (virologie), Infections à coronavirus (épidémiologie), Mammographie (MeSH), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (virologie), Pneumopathie virale (épidémiologie), Sujet âgé (MeSH), Tumeurs du sein (complications), Tumeurs du sein (diagnostic), Tumeurs du sein (épidémiologie).
MESH :
- diagnostic : Tumeurs du sein.
- pathogénicité : Betacoronavirus.
- tendances : Dépistage de masse.
- virologie : Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Infections à coronavirus, Pneumopathie virale, Tumeurs du sein.
- complications : Adulte d'âge moyen, Dépistage précoce du cancer, Femelle, Humains, Infections à coronavirus, Mammographie, Pandémies, Pneumopathie virale, Sujet âgé, Tumeurs du sein.

English descriptors

KwdEn :
- Aged (MeSH), Betacoronavirus (pathogenicity), Breast Neoplasms (complications), Breast Neoplasms (diagnosis), Breast Neoplasms (epidemiology), COVID-19 (MeSH), Coronavirus Infections (complications), Coronavirus Infections (epidemiology), Coronavirus Infections (virology), Early Detection of Cancer (MeSH), Female (MeSH), Humans (MeSH), Mammography (MeSH), Mass Screening (trends), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (epidemiology), Pneumonia, Viral (virology), SARS-CoV-2 (MeSH).
MESH :
- complications : Breast Neoplasms, Coronavirus Infections, Pneumonia, Viral.
- diagnosis : Breast Neoplasms.
- epidemiology : Breast Neoplasms, Coronavirus Infections, Pneumonia, Viral.
- pathogenicity : Betacoronavirus.
- trends : Mass Screening.
- virology : Coronavirus Infections, Pneumonia, Viral.
- Aged, COVID-19, Early Detection of Cancer, Female, Humans, Mammography, Middle Aged, Pandemics, SARS-CoV-2.

Abstract

BACKGROUND/AIM

Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension.

PATIENTS AND METHODS

Data regarding breast cancer and respective screening programs were achieved through literature research and analysis.

RESULTS

Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000.

CONCLUSION

Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis.

DOI: 10.21873/invivo.12139
PubMed: 32871851
PubMed Central: PMC7652450

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 001900
to stream Main, to step Curation: 001900

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.</title>
<author><name sortKey="Vanni, Gianluca" sort="Vanni, Gianluca" uniqKey="Vanni G" first="Gianluca" last="Vanni">Gianluca Vanni</name>
<affiliation wicri:level="3"><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pellicciaro, Marco" sort="Pellicciaro, Marco" uniqKey="Pellicciaro M" first="Marco" last="Pellicciaro">Marco Pellicciaro</name>
<affiliation wicri:level="3"><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy marcopell62@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Materazzo, Marco" sort="Materazzo, Marco" uniqKey="Materazzo M" first="Marco" last="Materazzo">Marco Materazzo</name>
<affiliation wicri:level="3"><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bruno, Valentina" sort="Bruno, Valentina" uniqKey="Bruno V" first="Valentina" last="Bruno">Valentina Bruno</name>
<affiliation wicri:level="3"><nlm:affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Oldani, Chiara" sort="Oldani, Chiara" uniqKey="Oldani C" first="Chiara" last="Oldani">Chiara Oldani</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Economics and Engineering, University of Viterbo 'La Tuscia', Viterbo, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Economics and Engineering, University of Viterbo 'La Tuscia', Viterbo</wicri:regionArea>
<wicri:noRegion>Viterbo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pistolese, Chiara Adriana" sort="Pistolese, Chiara Adriana" uniqKey="Pistolese C" first="Chiara Adriana" last="Pistolese">Chiara Adriana Pistolese</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Buonomo, Chiara" sort="Buonomo, Chiara" uniqKey="Buonomo C" first="Chiara" last="Buonomo">Chiara Buonomo</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Caspi, Jonathan" sort="Caspi, Jonathan" uniqKey="Caspi J" first="Jonathan" last="Caspi">Jonathan Caspi</name>
<affiliation wicri:level="3"><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gualtieri, Paola" sort="Gualtieri, Paola" uniqKey="Gualtieri P" first="Paola" last="Gualtieri">Paola Gualtieri</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chiaravalloti, Agostino" sort="Chiaravalloti, Agostino" uniqKey="Chiaravalloti A" first="Agostino" last="Chiaravalloti">Agostino Chiaravalloti</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>IRCCS Neuromed, UOC Medicina Nucleare, Pozzilli, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>IRCCS Neuromed, UOC Medicina Nucleare, Pozzilli</wicri:regionArea>
<wicri:noRegion>Pozzilli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Palombi, Leonardo" sort="Palombi, Leonardo" uniqKey="Palombi L" first="Leonardo" last="Palombi">Leonardo Palombi</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Piccione, Emilio" sort="Piccione, Emilio" uniqKey="Piccione E" first="Emilio" last="Piccione">Emilio Piccione</name>
<affiliation wicri:level="3"><nlm:affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Buonomo, Oreste Claudio" sort="Buonomo, Oreste Claudio" uniqKey="Buonomo O" first="Oreste Claudio" last="Buonomo">Oreste Claudio Buonomo</name>
<affiliation wicri:level="3"><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020 Sep-Oct</date>
<idno type="RBID">pubmed:32871851</idno>
<idno type="pmid">32871851</idno>
<idno type="doi">10.21873/invivo.12139</idno>
<idno type="pmc">PMC7652450</idno>
<idno type="wicri:Area/Main/Corpus">001900</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001900</idno>
<idno type="wicri:Area/Main/Curation">001900</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001900</idno>
<idno type="wicri:Area/Main/Exploration">001900</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.</title>
<author><name sortKey="Vanni, Gianluca" sort="Vanni, Gianluca" uniqKey="Vanni G" first="Gianluca" last="Vanni">Gianluca Vanni</name>
<affiliation wicri:level="3"><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pellicciaro, Marco" sort="Pellicciaro, Marco" uniqKey="Pellicciaro M" first="Marco" last="Pellicciaro">Marco Pellicciaro</name>
<affiliation wicri:level="3"><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy marcopell62@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Materazzo, Marco" sort="Materazzo, Marco" uniqKey="Materazzo M" first="Marco" last="Materazzo">Marco Materazzo</name>
<affiliation wicri:level="3"><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bruno, Valentina" sort="Bruno, Valentina" uniqKey="Bruno V" first="Valentina" last="Bruno">Valentina Bruno</name>
<affiliation wicri:level="3"><nlm:affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Oldani, Chiara" sort="Oldani, Chiara" uniqKey="Oldani C" first="Chiara" last="Oldani">Chiara Oldani</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Economics and Engineering, University of Viterbo 'La Tuscia', Viterbo, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Economics and Engineering, University of Viterbo 'La Tuscia', Viterbo</wicri:regionArea>
<wicri:noRegion>Viterbo</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pistolese, Chiara Adriana" sort="Pistolese, Chiara Adriana" uniqKey="Pistolese C" first="Chiara Adriana" last="Pistolese">Chiara Adriana Pistolese</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Buonomo, Chiara" sort="Buonomo, Chiara" uniqKey="Buonomo C" first="Chiara" last="Buonomo">Chiara Buonomo</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Caspi, Jonathan" sort="Caspi, Jonathan" uniqKey="Caspi J" first="Jonathan" last="Caspi">Jonathan Caspi</name>
<affiliation wicri:level="3"><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gualtieri, Paola" sort="Gualtieri, Paola" uniqKey="Gualtieri P" first="Paola" last="Gualtieri">Paola Gualtieri</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chiaravalloti, Agostino" sort="Chiaravalloti, Agostino" uniqKey="Chiaravalloti A" first="Agostino" last="Chiaravalloti">Agostino Chiaravalloti</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>IRCCS Neuromed, UOC Medicina Nucleare, Pozzilli, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>IRCCS Neuromed, UOC Medicina Nucleare, Pozzilli</wicri:regionArea>
<wicri:noRegion>Pozzilli</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Palombi, Leonardo" sort="Palombi, Leonardo" uniqKey="Palombi L" first="Leonardo" last="Palombi">Leonardo Palombi</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Piccione, Emilio" sort="Piccione, Emilio" uniqKey="Piccione E" first="Emilio" last="Piccione">Emilio Piccione</name>
<affiliation wicri:level="3"><nlm:affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Buonomo, Oreste Claudio" sort="Buonomo, Oreste Claudio" uniqKey="Buonomo O" first="Oreste Claudio" last="Buonomo">Oreste Claudio Buonomo</name>
<affiliation wicri:level="3"><nlm:affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome</wicri:regionArea>
<placeName><settlement type="city">Rome</settlement>
<region nuts="2">Latium</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">In vivo (Athens, Greece)</title>
<idno type="eISSN">1791-7549</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>Breast Neoplasms (complications)</term>
<term>Breast Neoplasms (diagnosis)</term>
<term>Breast Neoplasms (epidemiology)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (virology)</term>
<term>Early Detection of Cancer (MeSH)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Mammography (MeSH)</term>
<term>Mass Screening (trends)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (virology)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Betacoronavirus (pathogénicité)</term>
<term>Dépistage de masse (tendances)</term>
<term>Dépistage précoce du cancer (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Mammographie (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Sujet âgé (MeSH)</term>
<term>Tumeurs du sein (complications)</term>
<term>Tumeurs du sein (diagnostic)</term>
<term>Tumeurs du sein (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term>
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term>
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Dépistage de masse</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Mass Screening</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>COVID-19</term>
<term>Early Detection of Cancer</term>
<term>Female</term>
<term>Humans</term>
<term>Mammography</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Dépistage précoce du cancer</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infections à coronavirus</term>
<term>Mammographie</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
<term>Sujet âgé</term>
<term>Tumeurs du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND/AIM</b>
</p>
<p>Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>PATIENTS AND METHODS</b>
</p>
<p>Data regarding breast cancer and respective screening programs were achieved through literature research and analysis.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSION</b>
</p>
<p>Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32871851</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1791-7549</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>34</Volume>
<Issue>5</Issue>
<PubDate><MedlineDate>2020 Sep-Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>In vivo (Athens, Greece)</Title>
<ISOAbbreviation>In Vivo</ISOAbbreviation>
</Journal>
<ArticleTitle>Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.</ArticleTitle>
<Pagination><MedlinePgn>3047-3053</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.21873/invivo.12139</ELocationID>
<Abstract><AbstractText Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">Coronavirus disease is spreading worldwide. Due to fast transmission and high fatality rate drastic emergency restrictions were issued. During the lockdown, only urgent medical services are guaranteed. All non-urgent services, as breast cancer (BC) screening, are temporarily suspended. The potential of breast cancer screening programs in increasing the survival rate and decreasing the mortality rate has been widely confirmed. Suspension could lead to worse outcomes for breast cancer patients. Our study aimed to analyse the data and provide estimates regarding the temporary BC screening suspension.</AbstractText>
<AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Data regarding breast cancer and respective screening programs were achieved through literature research and analysis.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Considering three different scenarios with respect to the lockdown's impact on breast cancer screening, we estimate that approximately 10,000 patients could have a missed diagnosis during these 3 months. Considering a 6-month period, as suggested by the Imperial college model, the number of patients who will not receive a diagnosis will rise to 16,000.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Breast cancer screening should be resumed as soon as possible in order to avoid further breast cancer missed diagnosis and reduce the impact of delayed diagnosis.</AbstractText>
<CopyrightInformation>Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vanni</LastName>
<ForeName>Gianluca</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pellicciaro</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy marcopell62@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Materazzo</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bruno</LastName>
<ForeName>Valentina</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Oldani</LastName>
<ForeName>Chiara</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Economics and Engineering, University of Viterbo 'La Tuscia', Viterbo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pistolese</LastName>
<ForeName>Chiara Adriana</ForeName>
<Initials>CA</Initials>
<AffiliationInfo><Affiliation>Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Buonomo</LastName>
<ForeName>Chiara</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Emergency and Admission, Critical Care Medicine, Pain Medicine and Anesthetic Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Caspi</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gualtieri</LastName>
<ForeName>Paola</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chiaravalloti</LastName>
<ForeName>Agostino</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>IRCCS Neuromed, UOC Medicina Nucleare, Pozzilli, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Palombi</LastName>
<ForeName>Leonardo</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Piccione</LastName>
<ForeName>Emilio</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Section of Gynecology, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Buonomo</LastName>
<ForeName>Oreste Claudio</ForeName>
<Initials>OC</Initials>
<AffiliationInfo><Affiliation>Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Greece</Country>
<MedlineTA>In Vivo</MedlineTA>
<NlmUniqueID>8806809</NlmUniqueID>
<ISSNLinking>0258-851X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055088" MajorTopicYN="Y">Early Detection of Cancer</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008327" MajorTopicYN="N">Mammography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">SARS-SOV-2</Keyword>
<Keyword MajorTopicYN="N">breast cancer</Keyword>
<Keyword MajorTopicYN="N">breast cancer screening</Keyword>
<Keyword MajorTopicYN="N">early diagnosis</Keyword>
<Keyword MajorTopicYN="N">local advanced diagnosis</Keyword>
<Keyword MajorTopicYN="N">mammography</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>06</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>06</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>9</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>9</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32871851</ArticleId>
<ArticleId IdType="pii">34/5/3047</ArticleId>
<ArticleId IdType="doi">10.21873/invivo.12139</ArticleId>
<ArticleId IdType="pmc">PMC7652450</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Int J Mol Sci. 2017 Jul 07;18(7):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28686211</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>In Vivo. 2019 Nov-Dec;33(6):1879-1884</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31662515</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1677-1679</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109012</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Radiother. 2015 Aug;19(5):295-302</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26188735</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Breast Cancer. 2014;2014:469803</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24672730</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Breast Cancer. 2014 Aug;14(4):235-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24703317</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Surg Oncol. 2018 Oct;25(10):2829-2838</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29968031</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Anticancer Res. 2001 May-Jun;21(3C):2091-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11501831</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer. 2013 Jun 1;119(11):2022-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23504860</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2015 Apr 9;372(15):1381-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25853741</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>World J Surg. 2019 Mar;43(3):839-845</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30456482</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Biochem Biophys. 2015 Jun;72(2):333-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25543329</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Breast Health. 2020 Mar 25;16(2):86-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32285027</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Breast. 2013 Apr;22(2):101-108</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23422255</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Screen. 2012;19 Suppl 1:5-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22972806</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Oncol. 2020 May 22;10:938</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32574281</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Radiol. 2017 Jul;27(7):2737-2743</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27807699</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Rev Med Pharmacol Sci. 2017 Mar;21(6):1341-1345</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28387892</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Breast Cancer Res. 2011;13(6):R134</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22204661</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>In Vivo. 2020 Jun;34(3 Suppl):1651-1659</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32503825</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>In Vivo. 2020 Jun;34(3 Suppl):1661-1665</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32503826</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):288-291</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32100979</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Med Inform. 2018 Feb;110:1-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29331247</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Cancer. 2017 Apr;75:109-116</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28222306</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Biol Sci. 2017 Nov 1;13(11):1387-1397</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29209143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Radiology. 2015 Dec;277(3):663-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26599926</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Cancer. 2019 Apr 15;144(8):1941-1953</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30350310</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Wai Ke Za Zhi. 2020 May 1;58(5):331-336</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32096395</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2019 Dec 16;14(12):e0226352</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31841563</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Insights Imaging. 2012 Feb;3(1):7-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22695994</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2015 Jun 11;372(24):2353-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26039523</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Radiol. 1996 Apr;51(4):277-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8617041</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Rev Med Pharmacol Sci. 2016 Jul;20(14):2950-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27460720</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mech Behav Biomed Mater. 2018 Feb;78:420-426</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29223730</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CA Cancer J Clin. 2018 Nov;68(6):394-424</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30207593</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>In Vivo. 2017 01-02;31(1):101-110</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28064227</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2005 Oct 27;353(17):1784-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16251534</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tumori. 2002 May-Jun;88(3):S48-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12365390</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer. 1994 Mar 15;73(6):1666-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8156494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Sci. 2011 Mar;102(3):509-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21175994</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Italie</li>
<li>Oman</li>
</country>
<region><li>Latium</li>
</region>
<settlement><li>Rome</li>
</settlement>
</list>
<tree><country name="Italie"><region name="Latium"><name sortKey="Vanni, Gianluca" sort="Vanni, Gianluca" uniqKey="Vanni G" first="Gianluca" last="Vanni">Gianluca Vanni</name>
</region>
<name sortKey="Bruno, Valentina" sort="Bruno, Valentina" uniqKey="Bruno V" first="Valentina" last="Bruno">Valentina Bruno</name>
<name sortKey="Buonomo, Chiara" sort="Buonomo, Chiara" uniqKey="Buonomo C" first="Chiara" last="Buonomo">Chiara Buonomo</name>
<name sortKey="Buonomo, Oreste Claudio" sort="Buonomo, Oreste Claudio" uniqKey="Buonomo O" first="Oreste Claudio" last="Buonomo">Oreste Claudio Buonomo</name>
<name sortKey="Caspi, Jonathan" sort="Caspi, Jonathan" uniqKey="Caspi J" first="Jonathan" last="Caspi">Jonathan Caspi</name>
<name sortKey="Chiaravalloti, Agostino" sort="Chiaravalloti, Agostino" uniqKey="Chiaravalloti A" first="Agostino" last="Chiaravalloti">Agostino Chiaravalloti</name>
<name sortKey="Chiaravalloti, Agostino" sort="Chiaravalloti, Agostino" uniqKey="Chiaravalloti A" first="Agostino" last="Chiaravalloti">Agostino Chiaravalloti</name>
<name sortKey="Gualtieri, Paola" sort="Gualtieri, Paola" uniqKey="Gualtieri P" first="Paola" last="Gualtieri">Paola Gualtieri</name>
<name sortKey="Materazzo, Marco" sort="Materazzo, Marco" uniqKey="Materazzo M" first="Marco" last="Materazzo">Marco Materazzo</name>
<name sortKey="Oldani, Chiara" sort="Oldani, Chiara" uniqKey="Oldani C" first="Chiara" last="Oldani">Chiara Oldani</name>
<name sortKey="Palombi, Leonardo" sort="Palombi, Leonardo" uniqKey="Palombi L" first="Leonardo" last="Palombi">Leonardo Palombi</name>
<name sortKey="Piccione, Emilio" sort="Piccione, Emilio" uniqKey="Piccione E" first="Emilio" last="Piccione">Emilio Piccione</name>
<name sortKey="Pistolese, Chiara Adriana" sort="Pistolese, Chiara Adriana" uniqKey="Pistolese C" first="Chiara Adriana" last="Pistolese">Chiara Adriana Pistolese</name>
</country>
<country name="Oman"><region name="Latium"><name sortKey="Pellicciaro, Marco" sort="Pellicciaro, Marco" uniqKey="Pellicciaro M" first="Marco" last="Pellicciaro">Marco Pellicciaro</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/LockdownV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000673 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000673 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    LockdownV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32871851
   |texte=   Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32871851" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LockdownV1

This area was generated with Dilib version V0.6.38.
Data generation: Sun Jan 31 08:28:27 2021. Site generation: Sun Jan 31 08:33:49 2021

	Serveur d'exploration sur le confinement (PubMed)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le confinement (PubMed)

Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.

Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki